News & Press Release
2018
- All Categories
- Announcements
- HR and Organization
- Product Information
-
- 2018-10-15 Announcements Launching Sales of Jemina® Tablets, a Treatment for Dysmenorrhea
- 2018-10-10 Announcements BIO JAPAN 2018 Shigeki Shimasaki, Vice President and COO, to give a presentation Session on Regenerative Medicine [S-9], lead presentation by Dr. Tasuku Honjo (2018 Nobel Laureate in Physiology or Medicine), President, Foundation for Biomedical Research and Innovation at Kobe, Date: Thursday, October 11, 2018 15: 00 ~ 17: 00 Venue: Pacifico Yokohama F203 ・ F204
- 2018-08-15 Product Information Lunabell® Compound Tablets LD and ULD Authorized Generic
- 2018-07-02 Product Information Announcing Sales Launch of TITANBRIDGE® First Medical Device to Receive SAKIGAKE Designation Medical Device for the Treatment of Adductor Spasmodic Dysphonia
- 2018-07-02 Product Information Jemina® tablets（NPC-16）Approved in Japan for the Treatment of Dysmemorrhea
- 2018-06-06 Product Information Launch of RAPALIMUS® GEL 0.2% SAKIGAKE Designation & Orphan Drug Designation Treatment for Angiofibroma in Tuberous Sclerosis Complex
- 2018-05-31 HR and Organization Announcement of Personnel Changes
- 2018-05-15 Announcements Announcement of Private Placement of Shares to MEDIPAL HOLDINGS CORPORATION
- 2018-03-26 Product Information Marketing Approval Granted for RAPALIMUS GEL 0.2% (mTOR inhibitor), SAKIGAKE Designation & Orphan Drug Designation to Treat Angiofibroma in Tuberous Sclerosis Complex
- 2018-03-26 HR and Organization Announcement of Personnel Changes